Pain Patch Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Pain relief patch and arthritis pain patch are identified to relieve mild-to-moderate pain that is associated with arthritis, sprains, strains, and backache. Whereas, fentanyl patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. Fentanyl is in a class of medications.

MARKET DYNAMICS

The pain patch market is driving due to the growing prevalence of chronic diseases and rising geriatric population. However, stringent regulations, and lack of skilled personnel with sound technical knowledge hinder the market growth during the forecast period. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and increase in research funding boost the market growth.

MARKET SCOPE

The "Pain Patch Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pain patch market with detailed market segmentation by type, mode of administration and therapeutic use. The pain patch market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pain patch market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The pain patch market is segmented on the basis of type, mode of administration and therapeutic use. Based on type, the market is segmented as opioid & non-opioid. On the basis of mode of administration, the market is categorized as metered dose & microneedle patches. On the basis of therapeutic use, the market is categorized as pain relief, anesthesia, cough suppression, smoking cessation.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pain patch market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pain patch market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pain patch market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pain patch market in these regions.

MARKET PLAYERS

The report covers key developments in the pain patch market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pain patch market are anticipated to have lucrative growth opportunities in the future with the rising demand for pain patch in the global market. Below mentioned is the list of few companies engaged in the pain patch market.

The report also includes the profiles of key players in pain patch market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Allergan Plc (Actavis)
  
•   Endo International plc
  
•   GlaxoSmithKline plc
  
•   Hisamitsu Pharmaceutical Co.,Inc.
  
•   Janssen Pharmaceuticals, Inc.
  
•   Mylan N.V.
  
•   Pfizer, Inc.
  
•   Purdue Pharma L.P.
  
•   Sanofi-Aventis S.A.
  
•   West-Ward Pharmaceuticals Corporation
  
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Pain Patch Report Scope